TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Veterinary Vaccines Market Report & Forecast 2022-2028

Global and United States Veterinary Vaccines Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 30 September 2022
  • Pages :122
  • Formats:
  • Report Code:SMR-7400204
OfferClick for best price

Best Price: $3480

Veterinary Vaccines Market Size, Share 2022


Market Analysis and Insights: Global Veterinary Vaccines Market

The global Veterinary Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Veterinary Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Veterinary Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Veterinary Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Veterinary Vaccines market.

Global Veterinary Vaccines Scope and Market Size

Veterinary Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Veterinary Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Veterinary Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Inactivated Vaccines

Live Attenuated Vaccines

Conjugate Vaccines

Toxoid Vaccines

Recombinant Vaccines

DNA Vaccines

Others

Segment by Application

Veterinary Clinic

Veterinary Hospital

Veterinary Research Institute

Retail Pharmacy

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Elanco

Merck

Merial

Zoetis

Advaxis

AmpliPhi Biosciences

Aratana Therapeutics

ARKO Labs

Bayer

CanFel Therapeutics

Ceva Animal Health

Colorado Serum

Epitopix

Genus

Hygieia Biological Laboratories

ImmuCell

Nexvet

Nuovo Biologics

UBI

Valneva

Vetoquinol

Virbac

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Veterinary Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Veterinary Vaccines, with price, sales, revenue, and global market share of Veterinary Vaccines from 2019 to 2022.

Chapter 3, the Veterinary Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Veterinary Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Veterinary Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Veterinary Vaccines.

Chapter 13, 14, and 15, to describe Veterinary Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Veterinary Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Veterinary Vaccines Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 122 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million) Introduction
1.2 Global Veterinary Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Veterinary Vaccines Market Size for the Year 2017-2028
1.2.2 Global Veterinary Vaccines Market Size for the Year 2017-2028
1.3 Veterinary Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Veterinary Vaccines in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Veterinary Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Veterinary Vaccines Market Dynamics
1.4.1 Veterinary Vaccines Industry Trends
1.4.2 Veterinary Vaccines Market Drivers
1.4.3 Veterinary Vaccines Market Challenges
1.4.4 Veterinary Vaccines Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Veterinary Vaccines by Type
2.1 Veterinary Vaccines Market Segment by Type
2.1.1 Inactivated Vaccines
2.1.2 Live Attenuated Vaccines
2.1.3 Conjugate Vaccines
2.1.4 Toxoid Vaccines
2.1.5 Recombinant Vaccines
2.1.6 DNA Vaccines
2.1.7 Others
2.2 Global Veterinary Vaccines Market Size by Type (2017, 2022 & 2028)
2.3 Global Veterinary Vaccines Market Size by Type (2017-2028)
2.4 United States Veterinary Vaccines Market Size by Type (2017, 2022 & 2028)
2.5 United States Veterinary Vaccines Market Size by Type (2017-2028)
3 Veterinary Vaccines by Application
3.1 Veterinary Vaccines Market Segment by Application
3.1.1 Veterinary Clinic
3.1.2 Veterinary Hospital
3.1.3 Veterinary Research Institute
3.1.4 Retail Pharmacy
3.1.5 Others
3.2 Global Veterinary Vaccines Market Size by Application (2017, 2022 & 2028)
3.3 Global Veterinary Vaccines Market Size by Application (2017-2028)
3.4 United States Veterinary Vaccines Market Size by Application (2017, 2022 & 2028)
3.5 United States Veterinary Vaccines Market Size by Application (2017-2028)
4 Global Veterinary Vaccines Competitor Landscape by Company
4.1 Global Veterinary Vaccines Market Size by Company
4.1.1 Top Global Veterinary Vaccines Companies Ranked by Revenue (2021)
4.1.2 Global Veterinary Vaccines Revenue by Player (2017-2022)
4.2 Global Veterinary Vaccines Concentration Ratio (CR)
4.2.1 Veterinary Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Veterinary Vaccines in 2021
4.2.3 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Veterinary Vaccines Headquarters, Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million) Type
4.3.1 Global Veterinary Vaccines Headquarters and Area Served
4.3.2 Global Veterinary Vaccines Companies Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Veterinary Vaccines Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Veterinary Vaccines Market Size by Company
4.5.1 Top Veterinary Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Veterinary Vaccines Revenue by Players (2020, 2021 & 2022)
5 Global Veterinary Vaccines Market Size by Region
5.1 Global Veterinary Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Veterinary Vaccines Market Size by Region (2017-2028)
5.2.1 Global Veterinary Vaccines Market Size by Region: 2017-2022
5.2.2 Global Veterinary Vaccines Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Veterinary Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Veterinary Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Veterinary Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Veterinary Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Veterinary Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Veterinary Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Veterinary Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Veterinary Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Veterinary Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Veterinary Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Elanco
7.1.1 Elanco Company Details
7.1.2 Elanco Business Overview
7.1.3 Elanco Veterinary Vaccines Introduction
7.1.4 Elanco Revenue in Veterinary Vaccines Business (2017-2022)
7.1.5 Elanco Recent Development
7.2 Merck
7.2.1 Merck Company Details
7.2.2 Merck Business Overview
7.2.3 Merck Veterinary Vaccines Introduction
7.2.4 Merck Revenue in Veterinary Vaccines Business (2017-2022)
7.2.5 Merck Recent Development
7.3 Merial
7.3.1 Merial Company Details
7.3.2 Merial Business Overview
7.3.3 Merial Veterinary Vaccines Introduction
7.3.4 Merial Revenue in Veterinary Vaccines Business (2017-2022)
7.3.5 Merial Recent Development
7.4 Zoetis
7.4.1 Zoetis Company Details
7.4.2 Zoetis Business Overview
7.4.3 Zoetis Veterinary Vaccines Introduction
7.4.4 Zoetis Revenue in Veterinary Vaccines Business (2017-2022)
7.4.5 Zoetis Recent Development
7.5 Advaxis
7.5.1 Advaxis Company Details
7.5.2 Advaxis Business Overview
7.5.3 Advaxis Veterinary Vaccines Introduction
7.5.4 Advaxis Revenue in Veterinary Vaccines Business (2017-2022)
7.5.5 Advaxis Recent Development
7.6 AmpliPhi Biosciences
7.6.1 AmpliPhi Biosciences Company Details
7.6.2 AmpliPhi Biosciences Business Overview
7.6.3 AmpliPhi Biosciences Veterinary Vaccines Introduction
7.6.4 AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2017-2022)
7.6.5 AmpliPhi Biosciences Recent Development
7.7 Aratana Therapeutics
7.7.1 Aratana Therapeutics Company Details
7.7.2 Aratana Therapeutics Business Overview
7.7.3 Aratana Therapeutics Veterinary Vaccines Introduction
7.7.4 Aratana Therapeutics Revenue in Veterinary Vaccines Business (2017-2022)
7.7.5 Aratana Therapeutics Recent Development
7.8 ARKO Labs
7.8.1 ARKO Labs Company Details
7.8.2 ARKO Labs Business Overview
7.8.3 ARKO Labs Veterinary Vaccines Introduction
7.8.4 ARKO Labs Revenue in Veterinary Vaccines Business (2017-2022)
7.8.5 ARKO Labs Recent Development
7.9 Bayer
7.9.1 Bayer Company Details
7.9.2 Bayer Business Overview
7.9.3 Bayer Veterinary Vaccines Introduction
7.9.4 Bayer Revenue in Veterinary Vaccines Business (2017-2022)
7.9.5 Bayer Recent Development
7.10 CanFel Therapeutics
7.10.1 CanFel Therapeutics Company Details
7.10.2 CanFel Therapeutics Business Overview
7.10.3 CanFel Therapeutics Veterinary Vaccines Introduction
7.10.4 CanFel Therapeutics Revenue in Veterinary Vaccines Business (2017-2022)
7.10.5 CanFel Therapeutics Recent Development
7.11 Ceva Animal Health
7.11.1 Ceva Animal Health Company Details
7.11.2 Ceva Animal Health Business Overview
7.11.3 Ceva Animal Health Veterinary Vaccines Introduction
7.11.4 Ceva Animal Health Revenue in Veterinary Vaccines Business (2017-2022)
7.11.5 Ceva Animal Health Recent Development
7.12 Colorado Serum
7.12.1 Colorado Serum Company Details
7.12.2 Colorado Serum Business Overview
7.12.3 Colorado Serum Veterinary Vaccines Introduction
7.12.4 Colorado Serum Revenue in Veterinary Vaccines Business (2017-2022)
7.12.5 Colorado Serum Recent Development
7.13 Epitopix
7.13.1 Epitopix Company Details
7.13.2 Epitopix Business Overview
7.13.3 Epitopix Veterinary Vaccines Introduction
7.13.4 Epitopix Revenue in Veterinary Vaccines Business (2017-2022)
7.13.5 Epitopix Recent Development
7.14 Genus
7.14.1 Genus Company Details
7.14.2 Genus Business Overview
7.14.3 Genus Veterinary Vaccines Introduction
7.14.4 Genus Revenue in Veterinary Vaccines Business (2017-2022)
7.14.5 Genus Recent Development
7.15 Hygieia Biological Laboratories
7.15.1 Hygieia Biological Laboratories Company Details
7.15.2 Hygieia Biological Laboratories Business Overview
7.15.3 Hygieia Biological Laboratories Veterinary Vaccines Introduction
7.15.4 Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2017-2022)
7.15.5 Hygieia Biological Laboratories Recent Development
7.16 ImmuCell
7.16.1 ImmuCell Company Details
7.16.2 ImmuCell Business Overview
7.16.3 ImmuCell Veterinary Vaccines Introduction
7.16.4 ImmuCell Revenue in Veterinary Vaccines Business (2017-2022)
7.16.5 ImmuCell Recent Development
7.17 Nexvet
7.17.1 Nexvet Company Details
7.17.2 Nexvet Business Overview
7.17.3 Nexvet Veterinary Vaccines Introduction
7.17.4 Nexvet Revenue in Veterinary Vaccines Business (2017-2022)
7.17.5 Nexvet Recent Development
7.18 Nuovo Biologics
7.18.1 Nuovo Biologics Company Details
7.18.2 Nuovo Biologics Business Overview
7.18.3 Nuovo Biologics Veterinary Vaccines Introduction
7.18.4 Nuovo Biologics Revenue in Veterinary Vaccines Business (2017-2022)
7.18.5 Nuovo Biologics Recent Development
7.19 UBI
7.19.1 UBI Company Details
7.19.2 UBI Business Overview
7.19.3 UBI Veterinary Vaccines Introduction
7.19.4 UBI Revenue in Veterinary Vaccines Business (2017-2022)
7.19.5 UBI Recent Development
7.20 Valneva
7.20.1 Valneva Company Details
7.20.2 Valneva Business Overview
7.20.3 Valneva Veterinary Vaccines Introduction
7.20.4 Valneva Revenue in Veterinary Vaccines Business (2017-2022)
7.20.5 Valneva Recent Development
7.21 Vetoquinol
7.21.1 Vetoquinol Company Details
7.21.2 Vetoquinol Business Overview
7.21.3 Vetoquinol Veterinary Vaccines Introduction
7.21.4 Vetoquinol Revenue in Veterinary Vaccines Business (2017-2022)
7.21.5 Vetoquinol Recent Development
7.22 Virbac
7.22.1 Virbac Company Details
7.22.2 Virbac Business Overview
7.22.3 Virbac Veterinary Vaccines Introduction
7.22.4 Virbac Revenue in Veterinary Vaccines Business (2017-2022)
7.22.5 Virbac Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Veterinary Vaccines Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Veterinary Vaccines Market Trends
Table 3. Veterinary Vaccines Market Drivers
Table 4. Veterinary Vaccines Market Challenges
Table 5. Veterinary Vaccines Market Restraints
Table 6. Global Veterinary Vaccines Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Veterinary Vaccines Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Veterinary Vaccines Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Veterinary Vaccines Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Veterinary Vaccines Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Veterinary Vaccines Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Veterinary Vaccines Revenue Share by Player, 2017-2022
Table 13. Global Veterinary Vaccines Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2021)
Table 15. Top Players of Veterinary Vaccines in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Veterinary Vaccines Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Veterinary Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Veterinary Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Veterinary Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Veterinary Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Veterinary Vaccines Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Veterinary Vaccines Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Veterinary Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Veterinary Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Veterinary Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Veterinary Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Veterinary Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Elanco Company Details
Table 31. Elanco Business Overview
Table 32. Elanco Veterinary Vaccines Product
Table 33. Elanco Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 34. Elanco Recent Development
Table 35. Merck Company Details
Table 36. Merck Business Overview
Table 37. Merck Veterinary Vaccines Product
Table 38. Merck Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 39. Merck Recent Development
Table 40. Merial Company Details
Table 41. Merial Business Overview
Table 42. Merial Veterinary Vaccines Product
Table 43. Merial Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 44. Merial Recent Development
Table 45. Zoetis Company Details
Table 46. Zoetis Business Overview
Table 47. Zoetis Veterinary Vaccines Product
Table 48. Zoetis Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 49. Zoetis Recent Development
Table 50. Advaxis Company Details
Table 51. Advaxis Business Overview
Table 52. Advaxis Veterinary Vaccines Product
Table 53. Advaxis Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 54. Advaxis Recent Development
Table 55. AmpliPhi Biosciences Company Details
Table 56. AmpliPhi Biosciences Business Overview
Table 57. AmpliPhi Biosciences Veterinary Vaccines Product
Table 58. AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 59. AmpliPhi Biosciences Recent Development
Table 60. Aratana Therapeutics Company Details
Table 61. Aratana Therapeutics Business Overview
Table 62. Aratana Therapeutics Veterinary Vaccines Product
Table 63. Aratana Therapeutics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 64. Aratana Therapeutics Recent Development
Table 65. ARKO Labs Company Details
Table 66. ARKO Labs Business Overview
Table 67. ARKO Labs Veterinary Vaccines Product
Table 68. ARKO Labs Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 69. ARKO Labs Recent Development
Table 70. Bayer Company Details
Table 71. Bayer Business Overview
Table 72. Bayer Veterinary Vaccines Product
Table 73. Bayer Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 74. Bayer Recent Development
Table 75. CanFel Therapeutics Company Details
Table 76. CanFel Therapeutics Business Overview
Table 77. CanFel Therapeutics Veterinary Vaccines Product
Table 78. CanFel Therapeutics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 79. CanFel Therapeutics Recent Development
Table 80. Ceva Animal Health Company Details
Table 81. Ceva Animal Health Business Overview
Table 82. Ceva Animal Health Veterinary Vaccines Product
Table 83. Ceva Animal Health Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 84. Ceva Animal Health Recent Development
Table 85. Colorado Serum Company Details
Table 86. Colorado Serum Business Overview
Table 87. Colorado Serum Veterinary Vaccines Product
Table 88. Colorado Serum Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 89. Colorado Serum Recent Development
Table 90. Epitopix Company Details
Table 91. Epitopix Business Overview
Table 92. Epitopix Veterinary Vaccines Product
Table 93. Epitopix Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 94. Epitopix Recent Development
Table 95. Genus Company Details
Table 96. Genus Business Overview
Table 97. Genus Veterinary Vaccines Product
Table 98. Genus Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 99. Genus Recent Development
Table 100. Hygieia Biological Laboratories Company Details
Table 101. Hygieia Biological Laboratories Business Overview
Table 102. Hygieia Biological Laboratories Veterinary Vaccines Product
Table 103. Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 104. Hygieia Biological Laboratories Recent Development
Table 105. ImmuCell Company Details
Table 106. ImmuCell Business Overview
Table 107. ImmuCell Veterinary Vaccines Product
Table 108. ImmuCell Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 109. ImmuCell Recent Development
Table 110. Nexvet Company Details
Table 111. Nexvet Business Overview
Table 112. Nexvet Veterinary Vaccines Product
Table 113. Nexvet Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 114. Nexvet Recent Development
Table 115. Nuovo Biologics Company Details
Table 116. Nuovo Biologics Business Overview
Table 117. Nuovo Biologics Veterinary Vaccines Product
Table 118. Nuovo Biologics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 119. Nuovo Biologics Recent Development
Table 120. UBI Company Details
Table 121. UBI Business Overview
Table 122. UBI Veterinary Vaccines Product
Table 123. UBI Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 124. UBI Recent Development
Table 125. Valneva Company Details
Table 126. Valneva Business Overview
Table 127. Valneva Veterinary Vaccines Product
Table 128. Valneva Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 129. Valneva Recent Development
Table 130. Vetoquinol Company Details
Table 131. Vetoquinol Business Overview
Table 132. Vetoquinol Veterinary Vaccines Product
Table 133. Vetoquinol Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 134. Vetoquinol Recent Development
Table 135. Virbac Company Details
Table 136. Virbac Business Overview
Table 137. Virbac Veterinary Vaccines Product
Table 138. Virbac Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
Table 139. Virbac Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Vaccines Product Picture
Figure 2. Global Veterinary Vaccines Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Veterinary Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. United States Veterinary Vaccines Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Veterinary Vaccines Market Size 2017-2028 (US$ Million)
Figure 6. United States Veterinary Vaccines Market Share in Global 2017-2028
Figure 7. Veterinary Vaccines Report Years Considered
Figure 8. Product Picture of Inactivated Vaccines
Figure 9. Product Picture of Live Attenuated Vaccines
Figure 10. Product Picture of Conjugate Vaccines
Figure 11. Product Picture of Toxoid Vaccines
Figure 12. Product Picture of Recombinant Vaccines
Figure 13. Product Picture of DNA Vaccines
Figure 14. Product Picture of Others
Figure 15. Global Veterinary Vaccines Market Share by Type in 2022 & 2028
Figure 16. Global Veterinary Vaccines Market Size by Type (2017-2028) & (US$ Million)
Figure 17. Global Veterinary Vaccines Market Share by Type (2017-2028)
Figure 18. United States Veterinary Vaccines Market Share by Type in 2022 & 2028
Figure 19. United States Veterinary Vaccines Market Size by Type (2017-2028) & (US$ Million)
Figure 20. United States Veterinary Vaccines Market Share by Type (2017-2028)
Figure 21. Product Picture of Veterinary Clinic
Figure 22. Product Picture of Veterinary Hospital
Figure 23. Product Picture of Veterinary Research Institute
Figure 24. Product Picture of Retail Pharmacy
Figure 25. Product Picture of Others
Figure 26. Global Veterinary Vaccines Market Share by Application in 2022 & 2028
Figure 27. Global Veterinary Vaccines Market Size by Application (2017-2028) & (US$ Million)
Figure 28. Global Veterinary Vaccines Market Share by Application (2017-2028)
Figure 29. United States Veterinary Vaccines Market Share by Application in 2022 & 2028
Figure 30. United States Veterinary Vaccines Market Size by Application (2017-2028) & (US$ Million)
Figure 31. United States Veterinary Vaccines Market Share by Application (2017-2028)
Figure 32. North America Veterinary Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 33. U.S. Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Canada Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Europe Veterinary Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. Germany Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. France Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. U.K. Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Italy Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Russia Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Asia-Pacific Veterinary Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 42. China Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Japan Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. South Korea Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. India Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Australia Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Taiwan Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Indonesia Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Thailand Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Malaysia Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Philippines Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Latin America Veterinary Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Mexico Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Brazil Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Argentina Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Middle East & Africa Veterinary Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 57. Turkey Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 59. U.A.E Veterinary Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 60. Elanco Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 61. Merck Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 62. Merial Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 63. Zoetis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 64. Advaxis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 65. AmpliPhi Biosciences Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 66. Aratana Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 67. ARKO Labs Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 68. Bayer Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 69. CanFel Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 70. Ceva Animal Health Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 71. Colorado Serum Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 72. Epitopix Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 73. Genus Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 74. Hygieia Biological Laboratories Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 75. ImmuCell Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 76. Nexvet Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 77. Nuovo Biologics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 78. UBI Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 79. Valneva Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 80. Vetoquinol Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 81. Virbac Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount